| Officer | Age | In this role | Joined | 2024 pay | Source |
|---|---|---|---|---|---|
|
Kevin Conroy
Also a director
President and CEO
Title from the Form 4 dated Mar 23, 2026
|
59 | Not stated | Not stated | $15,539,378 | |
|
Aaron Bloomer
EVP, Chief Financial Officer
Title from the Form 4 dated Mar 23, 2026
|
39 | Not stated | Not stated | $7,186,788 | |
|
James Herriott
SVP, General Counsel & Sec
Title from the Form 4 dated Mar 23, 2026
|
45 |
Since 2022
4 years
|
Not stated | Not reported | |
|
Brian Baranick
EVP, GM, Precision Oncology
Title from the Form 4 dated Mar 23, 2026
|
47 | Not stated | Not stated | $4,399,668 | |
|
Sarah Condella
EVP, Human Resources
Title from the Form 4 dated Mar 23, 2026
|
44 | Not stated | 2012 | $2,645,555 | |
|
Jacob Orville
EVP, GM, Screening
Title from the Form 4 dated Mar 23, 2026
|
51 | Not stated | Not stated | $4,433,192 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 29, 2025 states there were none.
Read it in the proxyLoading...
